1 completed, 1 recruiting, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Parkinson Disease Dementia: new trials by email Literature Review of Parkinson Disease Dementia trials Research Report on Parkinson Disease Dementia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments Tributyrin, Placebo - Parkinson Disease, Parkinson Disease Dementia | Phase 1 / Phase 2 | Recruiting | Prabesh Kanel | 45 | 2025-11-07 | 2025-11-12 |
| ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial) ATH-1017, Placebo - Parkinson Disease Dementia, Dementia With Lewy Bodies | Phase 2 | Terminated | LeonaBio | 28 | 2022-01-20 | 2025-03-04 |
| OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 ANAVEX2-73 - Parkinson Disease Dementia | Phase 2 | Completed | Anavex Life Sciences Corp. | 132 | 2019-10-10 | 2022-08-01 |
Deafness, Autosomal Recessive 39 (1) · Dementia (1) · Lewy Body Disease (1) · Parkinson Disease (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Parkinsonian Disorders (2) · Synucleinopathies (2) · Mental Disorders (1) · Neurocognitive Disorders (1)
tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (1) · tributyrin (1)
Anavex Life Sciences Corp. (1) · LeonaBio (1) · Prabesh Kanel (1)
United States (2) · Australia (1) · Spain (1)